BALCX | CBLRX | BALCX / CBLRX | |
Total Expense Ratio | 1.31 | 1.18 | 111% |
Annual Report Gross Expense Ratio | 1.31 | 1.18 | 111% |
Fund Existence | 24 years | 15 years | - |
Gain YTD | 9.274 | 8.967 | 103% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 256B | 10.1B | 2,535% |
Annual Yield % from dividends | 1.18 | 1.41 | 84% |
Returns for 1 year | 7.16 | 5.37 | 133% |
Returns for 3 years | 27.12 | 24.26 | 112% |
Returns for 5 years | 33.87 | 25.17 | 135% |
Returns for 10 years | 59.19 | 60.57 | 98% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ETEC | 22.22 | 0.36 | +1.65% |
iShares Breakthrough Envirtl Sol ETF | |||
AGMI | 40.43 | 0.38 | +0.95% |
Themes Silver Miners ETF | |||
PJP | 90.01 | 0.55 | +0.62% |
Invesco Pharmaceuticals ETF | |||
UMAY | 35.47 | -0.03 | -0.10% |
Innovator U.S. Equity Ultra BffrETF™-May | |||
MMIT | 23.85 | -0.05 | -0.19% |
NYLI MacKay Muni Intermediate ETF |